
via Phys.org
While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilised using extracellular vesicles (EVs), also known in the past as “cellular dust”.
A team of researchers from CNRS, AP-HP, INSERM and Paris Descartes and Paris Diderot Universities have tested these vesicles for the first time in a porcine model for the treatment of post-operative digestive fistulas. Their results, which yielded a 100% success rate and appear in the 23 October 2018 edition of ACS Nano, open the door to testing in humans and broader possibilities for applications.
Extracellular vesicles are matter that is released by cells. Seen for many years as not having any value, this ‘cellular dust’ has been studied and presents therapeutic properties similar to their mother cells, without their disadvantages: These vesicles do not divide, limiting the risk of cancer, and do not differentiate either, thus preventing the development of poor function. Furthermore, it appears that they can be produced by a single donor for several patients, and have already demonstrated their therapeutic potential in animals in repairing heart, liver and kidney lesions.
In the case of digestive fistula, in which there is abnormal communication between organs in the digestive tract or with the skin, regenerative medicine is an important therapeutic avenue to explore. Fistulas of this kind respond poorly to current treatments; they can develop following post-operative complications or an auto-immune disorders such as Crohn’s disease, which causes digestive tract dysfunction.
For the first time, scientists at the Matières et systèmes complexes Lab (CNRS/Université Paris Diderot), the Gastroenterology and Endoscopy Department at the Hôpital Européen Georges Pompidou (HEGP) AP-HP and the Laboratoire Imagerie de l’angiogénèse, plateforme d’imagerie du petit animal (INSERM/Université Paris Descartes/HEGP)1, used extracellular vesicles from stem cells to treat digestive fistula in a swine model. The study reveals that local injections into the fistula of a gel containing these vesicles results in the complete closure of post-operative digestive fistula.
Researchers intend to test the new approach in a perineal fistula model found in Crohn’s disease, with the hope of replacing the stem cell injections. The vesicle gel could be administered locally and easily and become a simpler, safer and more effective treatment.
Learn more: “Cellular dust” provides new hope for regenerative medicine
The Latest on: Extracellular vesicles
via Google News
The Latest on: Extracellular vesicles
- Kar?na Narbute's research in extracellular vesicles earns her Young Investigator Awardon January 21, 2021 at 7:50 am
Kar?na Narbute, Ph.D. is the latest recipient of STEM CELLS Translational Medicine's Young Investigator Award. The award fosters advancements in the field of stem cells and regenerative medicine by ...
- Codiak’s Versatile engEx™ Platform for Engineered Exosomes Published in the Journal Molecular Therapyon January 21, 2021 at 6:17 am
New publication details the characterization of novel scaffold proteins that can enable engineered exosomes with defined therapeutic properties ...
- Do Lysosomes Help Propagate Tau Seeds?on January 14, 2021 at 4:00 pm
Aggregated tau can be passed between cells in tiny vesicles known as exosomes ... Ralph Nixon at New York University agreed that it makes sense for extracellular tau to reach the cytosol via the ...
- Acoustofluidic centrifuge for nanoparticle enrichment and assortmenton January 14, 2021 at 6:29 am
Exosomes are nanoscale extracellular vesicles that can carry molecular cargo from cell to cell and are therefore a powerful vector/vehicle in biomedical research for drug delivery and biomolecular ...
- Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allografton January 13, 2021 at 2:28 am
AUSTIN, Texas, Jan. 12, 2021 /PRNewswire/ -- Direct Biologics, LLC, an industry leader in extracellular vesicle technology, announced today that the company has launched AmnioWrap™ placental ...
- Enhanced oral uptake of exosomes opens cell therapy alternativeon January 12, 2021 at 10:42 am
The findings, published in the peer-reviewed Journal of Extracellular Vesicles, could help develop new oral medications for treating patients with muscular dystrophy and heart failure. The study ...
- Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allografton January 12, 2021 at 10:21 am
Direct Biologics, LLC, an industry leader in extracellular vesicle technology, announced today that the company has launched AmnioWrap™ placental-based sheet allografts for clinical use.
- Study could help develop new oral medications for treating muscular dystrophy, heart failureon January 11, 2021 at 9:22 pm
Cell-derived exosomes are effective in treating disease when mixed with the dominant protein in breast milk and given orally, a new Smidt Heart Institute study of laboratory mice shows.
- Study could help develop new oral drugs for treating muscular dystrophy, heart failureon January 11, 2021 at 9:21 pm
The findings, published in the peer-reviewed Journal of Extracellular Vesicles, could help develop new oral medications for treating patients with muscular dystrophy and heart failure. The study ...
via Bing News